How to Buy Dynavax Technologies Stock
Dynavax Technologies Corp
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States.
Dynavax Technologies stock last closed at $11.72, up 0.34% from the previous day, and has increased 13.68% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.18 percentage points. Dynavax Technologies stock is currently +10.88% from its 52-week low of $10.57, and -22.64% from its 52-week high of $15.15.
There are currently 130.61M shares of DVAX outstanding. The market value of DVAX is $1.53B. In the last 24 hours, 1.45M DVAX shares were traded.
How to Buy Dynavax Technologies Stock
Wondering how to invest in Dynavax Technologies stock? Here's how.
- Decide where to buy Dynavax Technologies stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you figure out where to buy Dynavax Technologies stock.
- Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit funds into your brokerage account: Choose your payment method and add your details.
- Research Dynavax Technologies stock: The Dynavax Technologies ticker symbol is DVAX. Is Dynavax Technologies stock a good investment? Should you buy shares of DVAX? How do DVAX's underlying business fundamentals look? Do top analysts think Dynavax Technologies is a good buy? Why has DVAX's stock price moved recently? (Hint: Our stock research website can help you decide if DVAX is a good stock to buy).
- Make your DVAX buy order: Decide if you will purchase DVAX shares at the current market price or use a limit order to purchase DVAX shares at a given price.
- Keep an eye on your DVAX position: Create a watchlist to monitor your position in Dynavax Technologies stock.
Step 1: Decide where to buy Dynavax Technologies stock
You need a brokerage account in order to access the NASDAQ market and buy DVAX shares.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world financial markets: From Technology to Utilities, New York to Hong Kong — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by creating an account with eToro today.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen the best brokerage, it's time to fill out some personal details so you are able to invest in DVAX stock today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to open your new brokerage account.
- Submit your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've opened your account on apps for stock market, you can securely and quickly fund your account:
Watch the tutorial below to see the process of depositing funds into your new brokerage account.
Step 4: Research Dynavax Technologies stock
Once you have chosen the best place to buy Dynavax Technologies stock, it's very important to research their stock before you buy, so you truly wrap your head around the risk as well as the upside.
Dynavax Technologies quick stats
Dynavax Technologies Overview
WallStreetZen was built to help everyday investors perform better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on DVAX's stock page.
How is DVAX stock valued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge DVAX's intrinsic value.
Using relative valuations metrics:
- DVAX could be overvalued based on its P/B ratio of 2.46x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.15x
You can access additional valuation research on DVAX's stock here.
DVAX Financial Summary
Signs that DVAX is financially healthy:
- Total DVAX debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the DVAX balance sheet.
- There are more short-term assets than short-term liabilities on the DVAX balance sheet.
- DVAX's operating cash flow of $100.56M allows it to safely service it's debt of $252.42M.
Signs that DVAX is not financially healthy:
- DVAX earnings of $2.39M is not sufficient to cover its interest payments.
- DVAX profit margin has gone down from 40.5% to -2.8% in the past year.
- DVAX has a relatively high debt to equity ratio of 0.6.
Is Dynavax Technologies stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 3 sell side analysts who give recommendations on DVAX, the consensus analyst rating on DVAX is a Buy
It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are forecasting on the Dynavax Technologies stock forecast page.
DVAX Technicals
DVAX Earnings
Last year, DVAX revenue was $232.28M. In the past five year, DVAX's revenue has increased by 95.19% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 29.57%.
Dive into DVAX's earnings and revenue performance here.
Latest Insiders Trades at DVAX
Over the last year, executives and large shareholders at DVAX have sold more shares than they have bought.
Justin Burgess, Chief Accounting Officer of DVAX, was the latest DVAX insider to sell. They sold $171,571.50 worth of DVAX stock on Mar 1, 2024.
Learn more about who owns DVAX stock here.
Does DVAX stock generate passive income?
No, Dynavax Technologies doesn't provide an income stream by paying out dividends.
What others are saying about DVAX
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your DVAX buy order
You have two primary options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually sufficient. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a particular dollar amount, use a limit order.
Click the Open Trade button and your broker will place your order.
If you require more info about investing in stocks on eToro, click the how to video below:
Step 6: Keep an eye on your DVAX position
Now that you own some shares in DVAX, you'll want to keep up with your investment.
Create a watchlist to get alerted to the latest events about your DVAX stock.
DVAX Feed
How to Buy Stock in Dynavax Technologies
To reiterate, here are the 6 steps to buy stock in Dynavax Technologies:
- Decide where to buy Dynavax Technologies stock
- Open your brokerage account
- Deposit funds into your brokerage account
- Research Dynavax Technologies stock
- Make your DVAX buy order
- Keep an eye on your DVAX position
If you require a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get updates on your new investment in Dynavax Technologies, click the button below.
More Articles You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.